WilmerHale advised Voyager Therapeutics on the deal. Voyager Therapeutics, a gene therapy company developing life-changing treatments and next-generation adeno-associated virus (AAV) capsids, announced it entered into...
Voyager Therapeutics’ License Option Agreement with Novartis
Tenderly’s $40 Million Series B Financing
WilmerHale advised Tenderly on the deal. Tenderly, an Ethereum Blockchain startup experiencing hyper growth, announced the completion of a $40 million Series B financing. The company...
Coral Tree’s Investment in Subject Matter
Wilmer Cutler Pickering Hale and Dorr advised Subject Matter on the deal. Subject Matter, a leading creative advocacy agency, announced an investment by Coral Tree Partners,...
Houghton Mifflin Harcourt’s $2.8 Billion Merger Agreement with Veritas Capital
Wilmer Cutler Pickering Hale and Dorr advised Houghton Mifflin Harcourt on the deal while Milbank represented Veritas Capital. Houghton Mifflin Harcourt Company (HMH), a learning technology...
TMX’s Minority Investment of SigmaLogic
WilmerHale advised TMX on the deal. TMX Group Limited, an international financial services company, announced that it has closed an equity investment to acquire a minority...
Akamai Technologies’ $900 Million Acquisition of Linode
WilmerHale represented Akamai, while Latham & Watkins represented Linode on the transaction. Akamai Technologies, Inc. (NASDAQ: AKAM), the world’s most trusted solution to power and protect digital experiences,...
DriveWealth’s Acquisition of Crypto-Systems
Wilmer Cutler Pickering Hale and Dorr advised DriveWealth on the deal. DriveWealth, a pioneer in fractional investing and embedded finance, announced its acquisition of Crypto-Systems, LLC, a...
ImmPACT Bio’s $111 Million Series B Financing
Wilmer Cutler Pickering Hale and Dorr advised ImmPACT Bio on the deal. ImmPACT Bio, a clinical-stage company developing transformative logic-gate based chimeric antigen receptor (CAR) T-cell...
Nodexus’ $30 Million Series A Venture Financing
Wilmer Cutler Pickering Hale and Dorr advised Nodexus on the deal. Nodexus Inc., an emerging leader in the development of automated live cell characterization and isolation...
Magnite’s Acquisition of Nth Party
Wilmer Cutler Pickering Hale and Dorr advised Nth Party on the deal. Magnite, an independent sell-side advertising platform, announced that it acquired Nth Party, a startup...
Diamond Sports Group’s Agreement with Creditors
Wilmer Cutler Pickering Hale and Dorr advised Diamond Sports Group on the deal. Sinclair Broadcast Group subsidiary Diamond Sports Group (DSG) announced that it and Sinclair...
Carisma’s Collaboration Agreement with Moderna
Wilmer Cutler Pickering Hale and Dorr advised Carisma Therapeutics Inc. on the deal. Carisma Therapeutics Inc., a biopharmaceutical pioneer in engineered macrophage-based therapeutics, announced a strategic collaboration...